Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available, a trend ...

Meanwhile, the model layer keeps whiplashing. First, everyone used ChatGPT. Then Gemini was catching up. Now, it seems Claude ...

Uttar Pradesh Chief Minister Yogi Adityanath''s divine-grand Mahakumbh-25 event received appreciation not only in the country but worldwide, where over 66 crore devotees took dip of faith in 45 days.

If 2025 was the year that cybersecurity became a “geopolitical flashpoint,” according to Forrester, then 2026 will be one ...

Oregon and other western states will follow vaccine recommendations from a leading medical group instead of the Centers for ...

Precigen, Inc. , a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today provided an update on the rapid ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

KELOWNA, BC / / January 12, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW), (the "Company" or "Lexaria"), a ...